Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, May 2002, p. 723-725, Vol. 9, No. 3
1071-412X/02/$04.00+0 DOI: 10.1128/CDLI.9.3.723-724.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Diagnostic Medicine-Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas 66506
Received 4 December 2001/ Returned for modification 6 February 2002/ Accepted 2 March 2002
|
|
|---|
|
|
|---|
Seventy-four fecal samples from calves with acute diarrhea were tested. Fecal samples and supernatants of BRV-infected cell cultures previously tested by enzyme-linked immunosorbent assay (ELISA) with the Rotazyme II kit (Abbott Laboratories, Abbott Park, Ill.) were used as positive and negative controls for this study (1).
For examination by EM, 10% (wt/vol) suspensions of calf feces were homogenized in 0.01 M phosphate-buffered saline (PBS) (pH 7) and were centrifuged at 1,500 x g for 5 min. The supernatant was removed and centrifuged at 28,000 x g for 1 h. A 35-µl aliquot of pelleted material was treated with 0.7 ml of double-distilled water, 140 µl of phosphotungstic acid (pH 7), and 35 µl of 1% bovine serum albumin for 5 min and then was sprayed onto carbon-coated grids for viewing at x30,000 magnification. The manufacturer's instructions for testing of human fecal samples were followed to test the bovine feces using the Virogen Rotatest (Wampole Laboratories, Cranbury, N.J.), a rapid LAT which utilizes latex particles coated with antibodies specific for group A rotavirus antigens.
All components of the LFT system, including BRV antiserum, anti-mouse immunoglobulin G (IgG), antirotavirus antibody-gold conjugated, membrane-blocking reagent, and known positive and negative controls, were evaluated in a series of titration experiments to determine optimum concentrations for the assay. Criteria used in these experiments were the attainment of maximum signal strength for specific line formation (true-positive/true-negative result) with an absence of nonspecific line formation (false-positive/false-negative result) and low background staining. The colloidal gold particles (2 nm; BBI International, Cardiff, United Kingdom) and monoclonal antibody used to prepare the LFT indicator conjugate were handled following the manufacturer's instructions. Monoclonal antibody clone 3C10 (Research Diagnostics, Inc., Flanders, N.J.) specific to the BRV inner capsid protein p42 was titrated to determine the appropriate concentration needed to stabilize the colloidal gold prior to conjugation. The sensitivity of the resulting antibody-gold conjugate was assayed by immunoblotting onto nitrocellulose. Fecal samples were initially prepared as either 10% (wt/vol) suspensions from solid or semisolid feces or as 20% (vol/vol) suspensions from liquid feces in 0.01 M PBS (pH 7) that were centrifuged at 1,500 x g for 10 min, and the supernatants were stored in sterile vials at -80°C until used. After the LFT was optimized, the centrifugation step was eliminated on fresh samples.
Hi-flow Plus Mylar-backed nitrocellulose membranes (Millipore Corp., Bedford, Mass.) were cut into 6-cm by 6-mm strips and were etched at 2.1 and 3.3 cm from the end designated zone 1, the sample application site. Ten microliters of anti-BRV polyclonal antiserum (1:1,000) was spotted at the 2.1-cm mark (zone 2), and 10 µl of goat anti-mouse IgG (1:5,000) was spotted from 2.2 to 3.3 cm (zone 3). The membranes were allowed to air dry for 45 min at room temperature (RT). They were blocked by incubating with 1% casein enzymatic hydrolysate (Sigma, St. Louis, Mo.) for 1/2 h and were then washed twice for 5 min with 0.01 M Tris-buffered saline. After drying for 45 min at RT, the membranes were secured in plastic cassettes. The LFT was performed by adding a mixture of 30 µl of test sample, 30 µl of anti-BRV-gold colloid conjugate, and 140 µl of transport-facilitating agent (1% casein and polyethylene glycol 20,000 in PBS, pH 7.0) to the loading window (zone 1) of the plastic cassette. The sample is wicked by the Hi-flow Plus membrane from zone 1 into zones 2 and 3, which, respectively, are saturated with anti-BRV and anti-mouse IgG antibodies. Following incubation for 30 min at RT, the membrane was evaluated visually. A single colored line appearing in zone 3 (Fig. 1A) indicates the absence of BRV. The concurrent presence of colored lines in zones 2 and 3 (Fig. 1B) indicates the presence of BRV. The absence of line formation indicates an invalid test that must be repeated. Once the test result has developed, the reaction lines, which form within 2 min of sample application, are permanent.
![]() View larger version (169K): [in a new window] |
FIG. 1. LFT true-negative (A) and -positive (B) results.
|
Twenty-nine specimens were evaluated by comparing EM (reference method), the LAT, and the LFT (Table 1). When EM was the reference method, initial studies of 29 samples indicated 70 and 80% sensitivities of the LFT and LAT, respectively, with both being 100% specific. When the LAT was the reference test, the LFT was 75% sensitive and 91% specific. Forty-five additional specimens were evaluated by the LFT (Table 2) with the Virogen Rotatest LAT as the reference test, and there was complete agreement between the test results.
|
View this table: [in a new window] |
TABLE 1. Comparison of EM (reference standard) to LAT and LFT for BRV (n = 29)
|
|
View this table: [in a new window] |
TABLE 2. Comparison of LFT and LAT for BRV (n = 45)
|
The project was supported by funds from the KAES and the Dean's Fund Research, by NC-62 Regional USDA funds for enteric diseases of swine and cattle, and by revenue generated by the Kansas State University Veterinary Diagnostic Laboratory, Manhattan, Kans.
Contribution 01-436-J from the Kansas Agricultural Experiment Station, Manhattan. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»